Valeant closes Brazil plant; Weak drug production trips up Ireland;

> Valeant Pharmaceuticals has closed one plant it acquired in the buyout last year of Brazil's Probiotica Laboratorios and intends to close a second plant in the next 6 months. Story

> The FDA has approved the Kemwell plant in Bangalore, India, which is already producing tablets for the European and Australian markets. Item

> Vaccine maker Vabiotech has licensed Inviragen's proprietary Japanese encephalitis (JE) technology to produce a cell-derived vaccine for the Vietnam and Myanmar markets. Item

> Indian drugmaker Wockhardt says it will immediately launch a generic version of the epilepsy drug Lamotrigine in the U.S. after getting FDA approval. Item

> Pfizer ($PFE) has gotten an expanded indication for its top selling vaccine Prevnar, which the EU now says can be used on children and adolescents ages 6 to 17. Item

And Finally... Falling drug production in Ireland was cited as the key reason the country experienced a nearly 13% drop in total industrial output for the three months that ended Nov. 30. Item

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.